United States · FDA National Drug Code directory
Nabumetone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-210_d9ae8825-f28b-ba4e-e053-2995a90a4487
- Product NDC
- 76420-210
- Form
- TABLET
- Composition / generic term
- Nabumetone
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190626
- Source listing expiry
- 20261231
Source-listed ingredients
- NABUMETONE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 7 TABLET in 1 BOTTLE (76420-210-07) · 76420-210-07
- 10 TABLET in 1 BOTTLE (76420-210-10) · 76420-210-10
- 14 TABLET in 1 BOTTLE (76420-210-14) · 76420-210-14
- 20 TABLET in 1 BOTTLE (76420-210-20) · 76420-210-20
- 30 TABLET in 1 BOTTLE (76420-210-30) · 76420-210-30
- 60 TABLET in 1 BOTTLE (76420-210-60) · 76420-210-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →